ask="4.000"
ask_size="200"
average_daily_volume="9685"
bid="1.040"
bid_size="500"
book_value="0.843"
change="+0.015"
change_from_200_day_moving_average="-1.122"
change_from_50_day_moving_average="-0.592"
change_from_52_week_high="-3.505"
change_From_52_week_low="0.355"
change_in_percent="+0.861%"
close="1.745"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.456"
ebitda="-14.29M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.070"
eps_estimate_next_year="-0.330"
ex_dividend_date="N/A"
float_shares="25675000"
high="1.847"
high_52_weeks="5.250"
last_trade_date="3/16/2017"
last_trade_price="1.745"
last_trade_size="100"
last_trade_time="3:23pm"
low="1.745"
low_52_weeks="1.390"
market_capitalization="69.24M"
moving_average_200_day="2.867"
moving_average_50_day="2.337"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="6.000"
open="1.750"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-39.137%"
percent_change_from_50_day_moving_average="-25.342%"
percent_change_from_52_week_high="-66.762%"
percent_change_from_52_week_low="+25.540%"
previous_close="1.730"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.052"
price_per_sales="84.524"
revenue="812175.00"
shares_outstanding="39679000"
short_ratio="0.610"
stock_exchange="NCM"
symbol="OASM"
volume="2959"
weeks_range_52="1.390 - 5.250"
